iRhythm Holdings Valuation Multiples

iRhythm Holdings Overview

About iRhythm Holdings

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Founded

2006

HQ

Employees

2.4K

Website

irhythmtech.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $785M

EBITDA: $79M

EV

$4B

Valuation Multiples

Multiples.vc

Start free trial

iRhythm Holdings Financials

iRhythm Holdings reported last 12-month revenue of $785M and EBITDA of $79M.

In the same LTM period, iRhythm Holdings generated $556M in gross profit, $79M in EBITDA, and had net loss of ($34M).

iRhythm Holdings P&L

In the most recent fiscal year, iRhythm Holdings reported revenue of $747M and EBITDA of $69M.

iRhythm Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX

iRhythm Holdings Stock Performance

iRhythm Holdings has current market cap of $4B, and enterprise value of $4B.

iRhythm Holdings' stock price is $124.41.

iRhythm Holdings Valuation Multiples

iRhythm Holdings trades at 5.3x EV/Revenue multiple, and 52.6x EV/EBITDA.

iRhythm Holdings Financial Valuation Multiples

As of April 16, 2026, iRhythm Holdings has market cap of $4B and EV of $4B.

Equity research analysts estimate iRhythm Holdings' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

iRhythm Holdings has a P/E ratio of (119.3x).

iRhythm Holdings Margins & Growth Rates

iRhythm Holdings' revenue in the last 12 month grew by 17%.

iRhythm Holdings' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

iRhythm Holdings' rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

iRhythm Holdings' rule of X is 55% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

iRhythm Holdings Public Comps

See public comps and valuation multiples for other Medical Devices comps.

iRhythm Holdings M&A Activity

iRhythm Holdings acquired XXX companies to date.

Last acquisition by iRhythm Holdings was on XXXXXXXX, XXXXX. iRhythm Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

iRhythm Holdings Investment Activity

iRhythm Holdings invested in XXX companies to date.

iRhythm Holdings made its latest investment on XXXXXXXX, XXXXX. iRhythm Holdings invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).